Related references
Note: Only part of the references are listed.The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis
Vinit V. Oommen et al.
JOURNAL OF NEUROIMAGING (2016)
MRI detection of hypointense brain lesions in patients with multiple sclerosis: T1 spin-echo vs. gradient-echo
Sheena L. Dupuy et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
Maria Pia Sormani et al.
LANCET NEUROLOGY (2013)
Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs
M. P. Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Black holes in multiple sclerosis: definition, evolution, and clinical correlations
M. A. Sahraian et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Fast free-form deformation using graphics processing units
Marc Modat et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Surrogate endpoints for EDSS worsening in multiple sclerosis A meta-analytic approach
M. P. Sormani et al.
NEUROLOGY (2010)
Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
F. Barkhof et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MR in the diagnosis and monitoring of multiple sclerosis:: An overview
Alex Rovira et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis
Ij van den Elskamp et al.
MULTIPLE SCLEROSIS (2008)
Clinical-magnetic resonance imaging correlations in multiple sclerosis
R Zivadinov et al.
JOURNAL OF NEUROIMAGING (2005)
Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis
CM Dalton et al.
JOURNAL OF NEUROLOGY (2004)
Role of MRI in multiple sclerosis I: Inflammation and lesions
R Zivadinov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years
F Bagnato et al.
BRAIN (2003)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
Reconstructing a 3D structure from serial histological sections
S Ourselin et al.
IMAGE AND VISION COMPUTING (2001)
Share Paper
